Question 1

How many shares of ACAD does ProShare Advisors LLC own?

Accepted Answer

As of 2026-Q2, ProShare Advisors LLC holds 23,970 shares of ACAD (ACADIA Pharmaceuticals Inc.).

Question 2

What is ProShare Advisors LLC's ACAD position worth?

Accepted Answer

As of 2026-Q2, ProShare Advisors LLC's ACAD position is worth $606,441.

Question 3

Is ProShare Advisors LLC buying or selling ACAD?

Accepted Answer

In 2026-Q2, ProShare Advisors LLC decreased their ACAD position (-11.9% change in shares).

Question 4

When did ProShare Advisors LLC first buy ACAD?

Accepted Answer

Based on available 13F filings, ProShare Advisors LLC first reported a position in ACAD in 2024-Q3. They have held the position across 31 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	23,970	-11.9%	$606,441	0.0%	$25.30	0
2026-Q1	Decreased	27,197	-14.2%	$605,406	0.0%	$22.50	0
2025-Q4	Increased	31,678	+7.5%	$846,119	0.0%	$26.70	27
2025-Q3	Decreased	29,463	-13.4%	$628,740	0.0%	$21.32	0
2025-Q2	Decreased	34,016	-4.9%	$733,725	0.0%	$22.12	0
2025-Q1	Decreased	35,769	-14.0%	$594,123	0.0%	$17.07	0
2024-Q4	Increased	41,580	+28.3%	$762,993	0.0%	$16.69	31
2024-Q3	Increased	32,416	+21.8%	$498,558	0.0%	$15.69	29